Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease
Biomedicines. 2022 Jul 12;10(7):1680. doi: 10.3390/biomedicines10071680.ABSTRACTAdvanced…
An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study
J Pers Med. 2022 Jun 29;12(7):1074. doi: 10.3390/jpm12071074.ABSTRACTScreenwide…
Metformin and breast cancer: an opportunity for pharmacogenetics
Aging (Albany NY). 2022 Jul 18;14(14):5612-5613. doi: 10.18632/aging.204180.…
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphoma
EJHaem. 2020 Dec 9;2(1):109-111. doi: 10.1002/jha2.131. eCollection…
Correction: The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
Leukemia. 2022 Aug;36(8):2150. doi: 10.1038/s41375-022-01639-5.NO…
Facts and Hopes in Immunotherapy of Endometrial Cancer
Clin Cancer Res. 2022 Nov 14;28(22):4849-4860. doi: 10.1158/1078-0432.CCR-21-1564.ABSTRACTImmunotherapy…
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients
Ann Hematol. 2022 Sep;101(9):2053-2067. doi: 10.1007/s00277-022-04906-8.…
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
Haematologica. 2023 Jan 1;108(1):110-121. doi: 10.3324/haematol.2022.280805.ABSTRACTAxicabtagene…
Follicular lymphoma grade 3: a comprehensive review
Clin Adv Hematol Oncol. 2022 Jun;20(6):384-390.ABSTRACTFollicular…
Second-line CAR T cells for lymphomas
Lancet. 2022 Jun 18;399(10343):2247-2249. doi: 10.1016/S0140-6736(22)00790-5.NO…
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
Eur J Cancer. 2022 Aug;171:64-74. doi: 10.1016/j.ejca.2022.04.036.…
Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling
Am J Cancer Res. 2022 May 15;12(5):2173-2188. eCollection 2022.ABSTRACTThe…
